Kirsten Detrick

Kirsten Detrick is a board member at Orexo AB and a business executive with over 30 years of experience in the pharmaceutical industry. Kirsten has held various leadership positions at Amgen, Bristol-Myers Squibb, and Takeda. Kirsten's experience spans global marketing and commercial development, P&L leadership, and cross-functional team management. Kirsten is known for their ability to grow revenue and expand access to important medications. Kirsten's work has been especially important in recent years as they have helped lead their teams through the challenges of the COVID pandemic.

Kirsten Detrick has a Master of Business Administration (MBA) from The Tuck School of Business at Dartmouth and a BA in Chemistry (major) and Creative Writing (minor) from Middlebury College. Kirsten also participated in a Study Abroad Program at the University of Stirling.